NOVARTIS SALUD ANIMAL S.A. DE C.V., now operating as Elanco Salud Animal S.A. de C.V., is the Mexican subsidiary of Elanco Animal Health, a global leader in animal health. Originally the Mexican arm of Novartis Animal Health, the entity came under Eli Lilly's Elanco division after Lilly acquired Novartis Animal Health in 2015 for approximately $5.4 billion, and it later became part of the independent Elanco Animal Health company after its 2018 spin-off from Lilly. The company is active in foreign trade, importing and distributing veterinary pharmaceutical and nutritional products for farm animals and companion animals across Mexico, with significant import and export operations. It is registered in Mexico under tax ID A970129U21.
| Import | Export |
|---|---|
|
Trade Records
570
|
Trade Records
102
|
|
Suppliers
23
|
Buyers
1
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, NOVARTIS SALUD ANIMAL S.A. DE C.V. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the NOVARTIS SALUD ANIMAL S.A. DE C.V. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, NOVARTIS SALUD ANIMAL S.A. DE C.V. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore NOVARTIS SALUD ANIMAL S.A. DE C.V.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| ELANCO ANIMAL HEALTH KVP PHARMA VETERINAR PRODUKT | NOVARTIS SALUD ANIMAL S.A. DE C.V. | 2924 | 24 | $186,500 | 3,420 | Los Angeles |
| ELANCO ANIMAL HEALTH INC. | NOVARTIS SALUD ANIMAL S.A. DE C.V. | 1515 | 24 | $186,500 | 3,420 | Los Angeles |
| ELANCO US INC. | NOVARTIS SALUD ANIMAL S.A. DE C.V. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| LOHMANN ANIMAL HEALTH GMBH (BRE) | NOVARTIS SALUD ANIMAL S.A. DE C.V. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| DIETRICH ENGINEERING CONSULTANTS SA | NOVARTIS SALUD ANIMAL S.A. DE C.V. | 7307 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into NOVARTIS SALUD ANIMAL S.A. DE C.V.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| ELANCO ANIMAL HEALTH KVP PHARMA VETERINAR PRODUKT | NOVARTIS SALUD ANIMAL S.A. DE C.V. | 3307 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore NOVARTIS SALUD ANIMAL S.A. DE C.V.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access NOVARTIS SALUD ANIMAL S.A. DE C.V.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.